4-[6-(Methoxymethyl)-2-(methylsulfanyl)pyrimidin-4-yl]morpholine

Catalog No. :
ACKHET242
CAS No. :
338748-03-1
Molecular Formula :
C11H17N3O2S
Molecular Weight :
255.34

IUPAC Name:4-(6-(methoxymethyl)-2-(methylthio)pyrimidin-4-yl)morpholine

4-[6-(Methoxymethyl)-2-(methylsulfanyl)pyrimidin-4-yl]morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[6-(Methoxymethyl)-2-(methylsulfanyl)pyrimidin-4-yl]morpholine
IUPAC Name4-(6-(methoxymethyl)-2-(methylthio)pyrimidin-4-yl)morpholine
MDL No.MFCD01444070
Molecular FormulaC11H17N3O2S
Molecular Weight255.34
SMILESCSC1=NC(COC)=CC(N2CCOCC2)=N1
InChI KeyPYGSSPCFZDCNDH-UHFFFAOYSA-N
SynonymMETHYL [2-(METHYLSULFANYL)-6-MORPHOLINO-4-PYRIMIDINYL]METHYL ETHER;4-[6-(methoxymethyl)-2-(methylsulfanyl)pyrimidin-4-yl]morpholine;4-[6-(METHOXYMETHYL)-2-(METHYLSULFANYL)-4-PYRIMIDINYL]MORPHOLINE;Morpholine, 4-[6-(methoxymethyl)-2-(methylthio)-4-pyrimidinyl]-
CAS No.338748-03-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKHET242 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFDCL501 route compound structure diagram
    ACFDCL5011499503-95-5 In Stock
  4. Then
  5. ACKHET242 route product structure diagram
    ACKHET242338748-03-1
Inquiry

2. ACKHET242 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKHET242 route product structure diagram
    ACKHET242338748-03-1
Inquiry

Comments (0)